+ The most common side effects are GI-related nausea, mild constipation, or occasional fatigue particularly when starting or increasing the dose
Weeks 5 to 8: the 0.5 mg phase This is where things get real for most people
Clinical eligibility for GLP-1 drugs was determined using BMI and the following comorbidities as specified in NHIS: coronary heart disease, prior stroke, prior heart attack, angina, high blood pressure, and high cholesterol
Notably, the N-terminal region of FSP1 undergoes irreversible myristoylation with a 14-carbon saturated fatty acid, which facilitates its anchorage to the plasma membrane
References: Meister A
Always consult with your healthcare provider before switching between the injection and pill forms to make sure the transition is safe and effective for you